Benutzer: Gast  Login
Titel:

[Drug therapy of hormone-sensitive metastatic prostate cancer : Consensus paper of the AKO/AUO].

Dokumenttyp:
Journal Article; Article
Autor(en):
Ohlmann, C-H; Gschwend, J; Miller, K
Abstract:
The standard treatment of patients with metastatic, hormone-sensitive prostate cancer (mCSPC) currently consists of medical or surgical castration. The addition of a cytotoxic chemotherapy was unable to provide a survival benefit over castration alone in several clinical trials using different chemotherapy regimens.Even a preliminary clinical trial using a docetaxel-based chemohormonal combination did not show a survival benefit. In contrast, two more recently published clinical trials (CHAARTED...     »
Zeitschriftentitel:
Urologe A
Jahr:
2016
Band / Volume:
55
Heft / Issue:
9
Seitenangaben Beitrag:
1164-72
Sprache:
de
Volltext / DOI:
doi:10.1007/s00120-016-0178-2
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/27431813
Print-ISSN:
0340-2592
TUM Einrichtung:
Urologische Klinik und Poliklinik
 BibTeX